Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Therapeutic Modalities

Enfortumab Vedotin/Pembrolizumab Combo Beats Chemo in Phase III Breakthrough

The Phase III clinical trial, named EV-302/KEYNOTE-A39, has unveiled that immunotherapy can outperform chemo in urothelial bladder cancer for the first time.
Read More
Translational & Preclinical Development

Handbook for Stem Cell Research

This whitepaper by Sino Biological discusses the different types of stem cells based on their origin and potential, as well as the factors that direct their differentiation toward specific lineages or cell types.
Read More
Autoimmunity & Immunology

Cancer Immunotherapy Novel Targets: The Forefront of Immuno-Oncology Research

Cancer Immunotherapy Novel Targets and Immunotherapy are being finely tuned to optimise efficacy and minimise side effects, gradually becoming a standard, perhaps even predominant, method in cancer management.
Read More
Therapeutic Modalities

Compugen: Exploring New Pathways and Combinations in Immunotherapy

Looking at new pathways for ICIs and Compugen's triple pathway hypothesis may be paving the way for next-generation cancer immunotherapy.
Read More

Navigating the Pharma R&D Regulatory Landscape 2023

Our ‘Navigating the Regulatory Landscape’ eBook has been designed to provide you with invaluable insights into the intricacies of regulations & policies surrounding the challenges and opportunities of Real-World Data, genome editing, biomedical informatics, manufacturing and many more.
Read More
Therapeutic Modalities

European Commission Approves Genmab’s Subcutaneous Bispecific Antibody Tepkinly

The approval follows positive results from Genmab's 'Epcore' phase I/II clinical trial.
Read More

Immuno-Oncology Vs Chemotherapy: Exploring Treatment Synergies

Unpacking the potential of combining immuno-oncology and chemotherapy: understanding benefits, real-world impact, and addressing concerns.
Read More
Tumour Microenvironment

Spotlight on Padmanee Sharma: Conquering Cancer through Resilience and Innovation

Highlighting the exceptional contributions of Padmanee Sharma, whose unyielding determination led her to become a renowned physician and immunologist, reshaping the landscape of cancer research.
Read More
Therapeutic Modalities

NK Cell Therapies: Development, Application, and Challenges

Sourcing NK cells, expansion techniques, gene modification, quality control, safety, preservation, and delivery.
Read More
Translational & Preclinical Development

iBio Reports Antibody Hat-Trick in its In Vivo IO Programs

Significant progress in iBio's in vivo preclinical programs with positive data from three antibody candidates: anti-EGFRvIII, CCR8, and TROP-2 x CD3.
Read More
Biomarkers in Immuno-Oncology

Exploring Oncology Biomarkers in Early Clinical Trials and Precision Medicine: Challenges and Opportunities

The importance of validating hypotheses, understanding the biology of cancer progression, and utilising biomarkers in early screening to stratify populations and improve clinical endpoints.
Read More
Translational & Preclinical Development

Using Mouse Models for Preclinical Immuno Oncology

Unveiling advancements in preclinical immuno-oncology: Exploring humanized mouse models and human knock-in mice for targeted cancer therapies.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things immuno